Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/131065
Title: Initial experience of macular translocation in Singapore - One-year results
Authors: Au Eong, K.G. 
Keywords: Choroidal neovascolarisation
Macular degeneration
Myopia
Ophthalmologic surgical procedure
Vitrectomy
Issue Date: Sep-2004
Citation: Au Eong, K.G. (2004-09). Initial experience of macular translocation in Singapore - One-year results. Annals of the Academy of Medicine Singapore 33 (5) : 641-648. ScholarBank@NUS Repository.
Abstract: Introduction: This paper reports the 1-year results of the first 2 cases of macular translocation in Singapore. Clinical Picture: A 66-year-old female and a 45-year-old male Chinese presented with subfoveal choroidal neovascularisation (CNV) in their right eyes. The woman's condition was secondary to pathological myopia while the man's was idiopathic. Their preoperative best-corrected visual acuities were 6/15-2 and 6/30, respectively. Treatment: Both patients underwent macular translocation with punctate retinotomies and chorioscleral infolding (limited macular translocation) in their affected eye. Outcome: Both patients achieved effective macular translocation postoperatively. Their CNVs became extrafoveal and were ablated with conventional laser photocoagulation in the early postoperative period. They did not recur and their visual acuities improved to 6/9-1 and 6/12 at 1 year postoperatively, respectively. Conclusion: Macular translocation is a new treatment modality that offers patients with subfoveal CNV a chance of improving their vision, potentially to a level that may allow reading and driving.
Source Title: Annals of the Academy of Medicine Singapore
URI: http://scholarbank.nus.edu.sg/handle/10635/131065
ISSN: 03044602
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

17
checked on Nov 23, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.